Cited In for PMID: 17606707

Year	Number of Results
2007	1
2008	7
2009	11
2010	14
2011	10
2012	11
2013	6
2014	4
2015	3
2016	3
2017	4
2018	4
2019	3
2020	2
2021	3
2023	2
2024	0

1

Cancer vaccines: moving beyond current paradigms.

Schlom J, Arlen PM, Gulley JL. Schlom J, et al. Clin Cancer Res. 2007 Jul 1;13(13):3776-82. doi: 10.1158/1078-0432.CCR-07-0588. Clin Cancer Res. 2007. PMID: 17606707 Free PMC article. Review.

2

rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses.

Ye J, Wang H, Medina R, Chakraborty S, Sun M, Valenzuela A, Sang X, Zhang Y, Uher O, Zenka J, Pacak K, Zhuang Z. Ye J, et al. J Exp Clin Cancer Res. 2023 Jul 12;42(1):163. doi: 10.1186/s13046-023-02744-8. J Exp Clin Cancer Res. 2023. PMID: 37434263 Free PMC article.

3

Establishing the applicability of cancer vaccines in combination with chemotherapeutic entities: current aspect and achievable prospects.

Kothari N, Postwala H, Pandya A, Shah A, Shah Y, Chorawala MR. Kothari N, et al. Med Oncol. 2023 Apr 4;40(5):135. doi: 10.1007/s12032-023-02003-y. Med Oncol. 2023. PMID: 37014489 Review.

4

Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects.

Liu Z, Liu X, Liang J, Liu Y, Hou X, Zhang M, Li Y, Jiang X. Liu Z, et al. Front Immunol. 2021 Oct 4;12:765101. doi: 10.3389/fimmu.2021.765101. eCollection 2021. Front Immunol. 2021. PMID: 34675942 Free PMC article. Review.

5

Dual role of immunomodulation by crude polysaccharide from okra against carcinogenic liver injury in mice.

Hayaza S, Wahyuningsih SPA, Susilo RJK, Husen SA, Winarni D, Doong RA, Darmanto W. Hayaza S, et al. Heliyon. 2021 Feb 11;7(2):e06183. doi: 10.1016/j.heliyon.2021.e06183. eCollection 2021 Feb. Heliyon. 2021. PMID: 33659734 Free PMC article.

6

Next-Generation Immunotherapies to Improve Anticancer Immunity.

Shi Y, Tomczak K, Li J, Ochieng JK, Lee Y, Haymaker C. Shi Y, et al. Front Pharmacol. 2021 Jan 11;11:566401. doi: 10.3389/fphar.2020.566401. eCollection 2020. Front Pharmacol. 2021. PMID: 33505304 Free PMC article. Review.

7

Toll-Like Receptor 3 in Solid Cancer and Therapy Resistance.

Muresan XM, Bouchal J, Culig Z, Souček K. Muresan XM, et al. Cancers (Basel). 2020 Nov 2;12(11):3227. doi: 10.3390/cancers12113227. Cancers (Basel). 2020. PMID: 33147700 Free PMC article. Review.

8

Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity.

Uher O, Caisova V, Hansen P, Kopecky J, Chmelar J, Zhuang Z, Zenka J, Pacak K. Uher O, et al. Semin Oncol. 2019 Aug-Oct;46(4-5):385-392. doi: 10.1053/j.seminoncol.2019.10.004. Epub 2019 Nov 6. Semin Oncol. 2019. PMID: 31739997 Free PMC article. Review.

9

The Immune Checkpoint Kick Start: Optimization of Neoadjuvant Combination Therapy Using Game Theory.

West J, Robertson-Tessi M, Luddy K, Park DS, Williamson DFK, Harmon C, Khong HT, Brown J, Anderson ARA. West J, et al. JCO Clin Cancer Inform. 2019 Feb;3:1-12. doi: 10.1200/CCI.18.00078. JCO Clin Cancer Inform. 2019. PMID: 30742484 Free PMC article.

10

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.

Chiappori AA, Williams CC, Gray JE, Tanvetyanon T, Haura EB, Creelan BC, Thapa R, Chen DT, Simon GR, Bepler G, Gabrilovich DI, Antonia SJ. Chiappori AA, et al. Cancer Immunol Immunother. 2019 Mar;68(3):517-527. doi: 10.1007/s00262-018-2287-9. Epub 2018 Dec 27. Cancer Immunol Immunother. 2019. PMID: 30591959 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

79 results

Results by year